Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[New therapeutic option for leukemia patients, with FLT3/Aurora kinase inhibitor, KW-2449: strategy and comparison with other kinase inhibitors].

[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Aug 2008

Shiotsu Yukimasa

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aurora Kinases
Share to Drug Design
Share to Drug Evaluation, Preclinical
Share to Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fms-Like Tyrosine Kinase 3

Share to Leukemia

Share to Pyridines

Share to Pyrimidines

Source

Identifiers

PMID: 18800614

Genes

FLT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[New therapeutic option for leukemia patients, with FLT3/Aurora kinase inhibitor, KW-2449: strategy and comparison with other kinase inhibitors].PMID 18800614Read ↗

[New targets for molecular therapy of acute leukemia: a "single-hit" or "multiple-hit" strategy against signaling pathway].Semantic proximity Read ↗

[Ⅱ. Recent Advances and Problems of FLT3 Inhibitor in AML Treatment].Semantic proximity Read ↗

[Possibility of targeting FLT3 kinase for the treatment of leukemia].Semantic proximity Read ↗

[FLT3 kinase inhibitors for the treatment of acute leukemia].Semantic proximity Read ↗

[Advancesin FLT3 inhibitors for acute myeloid leukemia].Semantic proximity Read ↗

[The present status of, and problems with the development of FLT3 kinase inhibitors].Semantic proximity Read ↗

The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinasesSemantic proximity Read ↗

A comprehensive review on role of Aurora kinase inhibitors (AKIs) in cancer therapeuticsSemantic proximity Read ↗

Solid Cancer Treatment With Aurora Kinase Inhibitors: Towards a Personalized Medicine.Semantic proximity Read ↗

[Molecular targeted drugs against ALK fusions].Semantic proximity Read ↗

[The clinical safety and efficacy of the patients of acute myeloid leukemia with FLT3-ITD positive treated with sorafenib in combination with venetoclax and azactitidine regimen].Semantic proximity Read ↗

[Sorafenib monotherapy for FLT3-ITD positive acute myeloid leukemia: a case report].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.